1. Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double-blind, randomized, placebo-controlled trial. J Neurol Neurosurg Psychiatry. 2003;74(7):863-6. doi:10.1136/jnnp.74.7.863 PMid:12810768 PMCid:PMC1738567

2. Anand R, Gill KD, Mahdi AA. Therapeutics of Alzheimer's disease: past, present, and future. Neuropharmacology. 2014;76:27-50. doi:10.1016/j.neuropharm.2013.07.004 PMid:23891641

3. Asghari RM, Barari A, Abdi A, Hasrak K. The review of short-term concurrent training on expression of p53 and p21 tumor suppressor genes in men with prostate cancer.

4. Aydın E, Türkez H, Keleş MS. The effect of carvacrol on healthy neurons and N2a cancer cells: some biochemical, anticancerogenicity and genotoxicity studies. Cytotechnology. 2014;66:149-57. doi:10.1007/s10616-013-9547-5 PMid:23553016 PMCid:PMC3886536

5. Bazyar F, Shabani R, Elmiyeh A. The effects of endurance training and saffron extract on the expression of Bax, Bcl-2, and Caspase-3 genes in the hippocampal tissue of Alzheimer's male rats. J Jiroft Univ Med Sci. 2023;9(4):1151-9.

6. Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet. 2006;368(9533):387-403. doi:10.1016/S0140-6736(06)69113-7 PMid:16876668

7. Breitner JC, Gau BA, Welsh KA, Plassman BL, McDonald WM, Helms MJ, Anthony JC. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology. 1994;44(2):227 doi:10.1212/WNL.44.2.227 PMid:8309563

8. Butterfield DA. β-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. Chem Res Toxicol. 1997;10(5):495-506. doi:10.1021/tx960130e PMid:9168246

9. Cioffi F, Adam RH, Broersen K. Molecular mechanisms and genetics of oxidative stress in Alzheimer's disease. J Alzheimers Dis. 2019;72(4): 981-1017 doi:10.3233/JAD-190863 PMid:31744008 PMCid:PMC6971833

10. Clementi F, Fornasari D, Gotti C. Neuronal nicotinic receptors, important new players in brain function. Eur J Pharmacol. 2000;393(1-3):3-10. doi:10.1016/S0014-2999(00)00066-2 PMid:10770992

11. Dall'Igna OP, Fett P, Gomes MW, Souza DO, Cunha RA, Lara DR. Caffeine and adenosine A2a receptor antagonists prevent β-amyloid (25-35)-induced cognitive deficits in mice. Exp Neurol. 2007;203(1):241-5. doi:10.1016/j.expneurol.2006.08.008 PMid:17007839

12. Dastmalchi K, Dorman HD, Oinonen PP, Darwis Y, Laakso I, Hiltunen R. Chemical composition and in vitro antioxidative activity of a lemon balm (Melissa officinalis L.) extract. LWT Food Sci Technol. 2008;41(3):391-400. doi:10.1016/j.lwt.2007.03.007

13. Feng D, Wang MY, Liu J, Zhang HX, Chen X, Zhang RL, et al. Survival efficacy of MDS/AML patients with TP53 abnormal received allogeneic hematopoietic stem cell transplantation. Zhonghua Xue Ye Xue Za Zhi. 2023;44(3):222-9.

14. Ge YS, Teng WY, Zhang CD. Protective effect of cyclophilin A against Alzheimer's amyloid beta-peptide (25-35)-induced oxidative stress in PC12 cells. Chin Med J. 2009;122(6):716-24.

15. Ghasemi PA, Gorgij A, Rahimmalek M, Hamedi B. Phytochemical response of hyssop (Hyssopus officinalis L.) to foliar application of jasmonic acid.

16. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353-6. doi:10.1126/science.1072994 PMid:12130773

17. Jones GM, Sahakian BJ, Levy R, Warburton DM, Gray JA. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology (Berl). 1992;108:485-94. doi:10.1007/BF02247426 PMid:1410164

18. Ju Y, Tam KY. Pathological mechanisms and therapeutic strategies for Alzheimer's disease. Neural Regen Res. 2022;17(3):543-9. doi:10.4103/1673-5374.320970 PMid:34380884 PMCid:PMC8504384

19. Kihara T, Shimohama S, Sawada H, Kimura J, Kume T, Kochiyama H, Maeda T, Akaike A. Nicotinic receptor stimulation protects neurons against β-amyloid toxicity. Ann Neurol. 1997;42(2): 159-63. doi:10.1002/ana.410420205 PMid:9266724

20. Koo JH, Kang EB, Oh YS, Yang DS, Cho JY. Treadmill exercise decreases amyloid-β burden possibly via activation of SIRT-1 signaling in a mouse model of Alzheimer's disease. Exp Neurol. 2017;288:142-52. doi:10.1016/j.expneurol.2016.11.014 PMid:27889467

21. Larson EB, Wang LI, Bowen JD, McCormick WC, Teri L, Crane P, et al. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med. 2006;144(2):73-81. doi:10.7326/0003-4819-144-2-200601170-00004 PMid:16418406

22. Ngolab J, Honma P, Rissman RA. Reflections on the utility of the retina as a biomarker for Alzheimer's disease: a literature review. Neurol Ther. 2019;8:57-72. doi:10.1007/s40120-019-00173-4 PMid:31833024 PMCid:PMC6908534

23. Paterson D, Nordberg A. Neuronal nicotinic receptors in the human brain. Prog Neurobiol. 2000; 61(1):75-111. doi:10.1016/S0301-0082(99)00045-3 PMid:10759066

24. Pereira RP, Fachinetto R, de Souza Prestes A, Puntel RL, Santos da Silva GN, Heinzmann BM, et al. Antioxidant effects of different extracts from Melissa officinalis, Matricaria recutita and Cymbopogon citratus. Neurochem Res. 2009;34: 973-83. doi:10.1007/s11064-008-9861-z PMid:18853256

25. Perry N, Court G, Bidet N, Court J, Perry E. European herbs with cholinergic activities: potential in dementia therapy. Int J Geriatr Psychiatry. 1996; 11(12):1063-9. doi:10.1002/(SICI)1099-1166(199612)11:12<1063::AID-GPS532>3.0.CO;2-1

26. Radak Z, Suzuki K, Higuchi M, Balogh L, Boldogh I, Koltai E. Physical exercise, reactive oxygen species and neuroprotection. Free Radic Biol Med. 2016;98:187-96. doi:10.1016/j.freeradbiomed.2016.01.024 PMid:26828019

27. Reinsberger C. Of running mice and exercising humans-the quest for mechanisms and biomarkers of exercise-induced neurogenesis and plasticity. Dtsch Z Sportmed. 2015;66(2). doi:10.5960/dzsm.2015.165

28. Roth KA. Caspases, apoptosis, and Alzheimer disease: causation, correlation, and confusion. J Neuropathol Exp Neurol. 2001;60(9):829-38. doi:10.1093/jnen/60.9.829 PMid:11556539

29. Schliebs R. Basal forebrain cholinergic dysfunction in Alzheimer's disease-interrelationship with β-amyloid, inflammation and neurotrophin signaling. Neurochem Res. 2005;30:895-929 doi:10.1007/s11064-005-6962-9 PMid:16187224

30. Sepand M, Soodi M, Soleimani M, Hajimehdipoor H. Protective effects of Melissa officinalis extract against beta-amyloid-induced oxidative stress in PC12 cells. J Med Plants. 2012; 11(42):74-85.

31. Thomas AG, Dennis A, Bandettini PA, Johansen-Berg H. The effects of aerobic activity on brain structure. Front Psychol. 2012;3:86. doi:10.3389/fpsyg.2012.00086 PMid:22470361 PMCid:PMC3311131

32. Wake G, Court J, Pickering A, Lewis R, Wilkins R, Perry E. CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory. J Ethnopharmacol. 2000; 69 (2): 105-14. doi:10.1016/S0378-8741(99)00113-0 PMid:10687867

33. Xiao XQ, Wang R, Han YF, Tang XC. Protective effects of huperzine A on β-amyloid25-35 induced oxidative injury in rat pheochromocytoma cells. Neurosci Lett. 2000; 286 (3):155-8. doi:10.1016/S0304-3940(00)01088-0 PMid:10832008